top of page

HELLO!

If you’re a caregiver to a child with an AGO mutation, you’ll find helpful information here to support their development.
 

If you’re an experienced caregiver, scientist, or physician, and have updates or corrections to share, please contact us.

Our mission is to provide accurate and up-to-date resources for AGO caregivers.

Argonaute Syndrome: Understanding a Rare Genetic Disorder

Argonaute syndrome is a recently discovered ultra-rare genetic condition caused by mutations in the Ago1 and Ago2 genes. These genes are essential for regulating how our cells process genetic information, particularly in the brain. When they don't function properly, it can lead to significant developmental challenges.

 Children with this syndrome face a combination of neurological, physical, and behavioral challenges.

​

What Are the Symptoms?

Argonaute syndrome is marked by a wide range of symptoms, varying in severity from person to person. These include:

​

  • Intellectual and learning disabilities: Many children with Argonaute syndrome struggle with cognitive development, which affects their ability to learn and process information.

  • Delayed speech development: Speech milestones may be significantly delayed or impaired.

  • Motor delays: Physical development is often slower, with delays in crawling, walking, or other motor skills.

  • Epilepsy: Seizures are a common and often challenging symptom for children with Argonaute syndrome.

  • Floppy body (hypotonia): Low muscle tone is frequently observed, which can make physical movement and posture more difficult.

  • Autism spectrum disorder (ASD)-like behaviors: These can include difficulties with social interactions, communication, and repetitive behaviors.

  • Microcephaly: Some children have smaller head sizes than typical for their age.

  • Impaired coordination (ataxia): This can lead to unsteady movements and difficulty with balance.

  • Feeding difficulties: Infants may struggle to feed properly, which can lead to nutritional challenge

 

Key observations

  • Intellectual Disability & Speech Delay: Universal in both AGO1 and AGO2 mutations (~100%).

  • Epilepsy: More prominent in AGO1 mutations (~50%) compared to AGO2 (~10%).

  • Microcephaly: Significantly more frequent in AGO1 mutations (~50%) than AGO2 (~5%).

  • Autism-Like Behaviors: Twice as common in AGO1 (~40%) as in AGO2 (~20%).

  • Ataxia and Feeding Difficulties: Rare but slightly more frequent in AGO1 than AGO2.

 

Basics of diseases

​

The Ago1 and Ago2 genes play a crucial role in the brain's development by regulating which genes are turned on or off. They are part of a cellular system called the RNA-induced silencing complex (RISC), which ensures the proper functioning of many biological processes.

When mutations occur in these genes, the delicate balance of gene regulation is disrupted. This results in improper brain development and the wide array of symptoms seen in Argonaute syndrome.

​

Treatment Approaches

​

Currently, there is no cure for Argonaute syndrome. Treatment focuses on managing symptoms and improving quality of life

​

Medications:​

​​

  • Antiepileptic Drugs: To control seizures.​​

  • Supportive Therapies:

    • Physical and Occupational Therapy: To address motor difficulties and prevent contractures.

    • Speech Therapy: To assist with communication challenges.

    • Nutritional Support: Including feeding assistance or special diets as needed.

 

Caregiver Support and Resources

​

Caring for an individual with `Argonaute syndrome can be demanding. Support for caregivers is crucial:

​​​

  • Support Groups: Connecting with other families through organizations like the AGO Alliance can provide emotional support and practical advice. Join newsletter or facebook group.

  • Respite Care: Accessing temporary relief services to prevent caregiver burnout.

  • Professional Counseling: To address emotional and psychological needs.

  • Educational Materials: Understanding Argonaute syndrome and associated symptoms helps in managing everyday situations for our kids. â€‹

 

Content generated using ChatGPT

Rodzina 2023.jpg

About Us

We are a family of 5 with the eldest son, Albert, affected by Ago1 syndrome. We aim to develop a treatment for kids suffering from Argonaute syndrome that will improve their quality of life and offer a cure.

 

Please get in touch with us (Aldona and Aleks)  if you want to support us in our mission to develop a cure.

If you are a caregiver of a child affected by Argonaute syndrome, please join our online community in AGO Alliance.

Contact: contact@agoresearch.org

linkedin (2).png
facebook (5).png

Bank Details

AGO Alliance Poland

ul. Swieradowska 51B,

02-665 Warsaw, Poland

​

Account number: 

18 1600 1462 1717 3293 5000 0001

​

International transfers:

SWIFT: PPABPLPK (BNP PARIBAS)

IBAN:PL18 1600 1462 1717 3293 5000 0001 

​

​

bottom of page